These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34668450)

  • 1. Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia.
    Kong D; Li Y; Fu C; Hou M; Yan L; Shang J; Wang Z; Yin J; Yu Z; Wu D
    Leuk Lymphoma; 2022 Feb; 63(2):491-494. PubMed ID: 34668450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Von Willebrand's disease associated with Waldenström's macroglobulinemia].
    Laurin S; Maheu M
    Union Med Can; 1980 Aug; 109(8):1201-3. PubMed ID: 6782733
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acquired von Willebrand's disease].
    Berentsen S; Hammerstrøm J
    Tidsskr Nor Laegeforen; 1993 May; 113(12):1463-5. PubMed ID: 8332973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
    Butelet A; Poulain S; Jeanpierre E; Srour M; Nudel M; Chauvet P; Bauters A; Susen S; Dupont A; de Charette M
    Leuk Lymphoma; 2022 Dec; 63(13):3100-3104. PubMed ID: 36528585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-3. Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia (LPL/WM).
    Kobayashi Y
    Int J Hematol; 2019 Nov; 110(5):524-528. PubMed ID: 31494831
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand's syndrome in the course of Waldenström's disease.
    Mazurier C; Parquet-Gernez A; Descamps J; Bauters F; Goudemand M
    Thromb Haemost; 1980 Dec; 44(3):115-8. PubMed ID: 6781094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan].
    Sekiguchi N
    Rinsho Ketsueki; 2021; 62(8):1139-1148. PubMed ID: 34497201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waldenstrom macroglobulinaemia manifesting as acquired von Willebrand syndrome.
    Mohamed M
    Intern Med J; 2018 Jul; 48(7):888-891. PubMed ID: 29984508
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphoplasmacytic lymphoma exposed by haemoptysis and acquired von Willebrand syndrome.
    Coucke L; Marcelis L; Deeren D; Van Dorpe J; Lambein K; Devreese K
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):395-7. PubMed ID: 24469392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
    Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
    J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agents in the treatment of Waldenström's macroglobulinemia.
    Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I
    Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of refractory cold hemagglutinemia in MYD88 L265P mutation-negative Waldenström's macroglobulinemia with bortezomib.
    Izumi M; Tsunemine H; Suzuki Y; Tomita A; Kusumoto T; Kodaka T; Itoh K; Takahashi T
    Int J Hematol; 2015 Aug; 102(2):238-43. PubMed ID: 25794560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary problems associated with lymphoplasmacytic lymphoma (Waldenström's macroglobulinemia)].
    Aerts JG; de Jongh F; van Iperen CE; Lam KH; Hoogsteden HC; van Meerbeeck JP
    Ned Tijdschr Geneeskd; 2002 May; 146(21):999-1002. PubMed ID: 12058634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Tirabrutinib Monotherapy for Bing-Neel Syndrome in Waldenström's Macroglobulinemia.
    Sekiguchi N
    Intern Med; 2022 Dec; 61(23):3473-3474. PubMed ID: 35569973
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosis and treatment of Waldenström's macroglobulinemia.
    Louw VJ; Webb MJ
    Transfus Apher Sci; 2010 Apr; 42(2):193-7. PubMed ID: 20117052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.
    D'Aveni-Piney M; Divoux M; Busby-Venner H; Muller M; Broséus J; Feugier P
    J Med Case Rep; 2018 Jun; 12(1):164. PubMed ID: 29890999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.
    Mori N; Ohwashi M; Yoshinaga K; Mitsuhashi K; Tanaka N; Teramura M; Okada M; Shiseki M; Tanaka J; Motoji T
    PLoS One; 2013; 8(11):e80088. PubMed ID: 24224040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral simultaneous central retinal vein occlusion (CRVO) caused by waldenstrom's macroglobulinaemia with acquired von willebrand's disease.
    Casares PZ; Gillet DS; Verity DH; Rowson NR
    Br J Haematol; 2002 Jul; 118(1):344-7. PubMed ID: 12100172
    [No Abstract]   [Full Text] [Related]  

  • 20. [Waldenström's macroglobulinemia with pleuropulmonary, orbital and subcutaneous localisation. Favorable effect of chlorambucil].
    Godeau P; Sicard D; Herreman G; Slama G
    Sem Hop; 1972 Nov; 48(47):3111-6. PubMed ID: 4347005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.